Wellgistics Health (NASDAQ:WGRX) Upgraded to Sell at Wall Street Zen

Wellgistics Health (NASDAQ:WGRX) was upgraded by research analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Wellgistics Health in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Wellgistics Health presently has an average rating of “Sell”.

Wellgistics Health Stock Performance

Shares of NASDAQ WGRX opened at $2.98 on Friday. Wellgistics Health has a 52-week low of $2.81 and a 52-week high of $97.50. The stock has a market cap of $7.48 million, a P/E ratio of -0.07 and a beta of -1.47. The firm has a 50 day moving average price of $4.32 and a 200 day moving average price of $10.50.

Institutional Investors Weigh In On Wellgistics Health

Several institutional investors have recently bought and sold shares of WGRX. Raymond James Financial Inc. boosted its position in Wellgistics Health by 593.8% during the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock worth $52,000 after acquiring an additional 50,000 shares during the last quarter. XTX Topco Ltd raised its holdings in shares of Wellgistics Health by 195.1% in the fourth quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock valued at $42,000 after purchasing an additional 70,137 shares during the last quarter. Geode Capital Management LLC lifted its position in Wellgistics Health by 81.0% during the 4th quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock worth $195,000 after buying an additional 218,170 shares in the last quarter. Finally, Heights Capital Management Inc. acquired a new stake in shares of Wellgistics Health in the third quarter valued at about $2,588,000.

Wellgistics Health Company Profile

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.